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A systematic approach to process optimization for production of  rifamycin B was applied to a strain of 
Amycolatopsis mediterranei. Examination of the growth revealed 6 different morphologically distinct  
colonies on Bennett’s agar medium. Rifamycin B production in shake flasks by the six different colony 
types ranged between 0.5 and 1.2 g/l. There was a clear correlation between the colony morphology and 
rifamycin B productivity. The highest yield of rifamycin B (1.03-1.2 g/l) was obtained by using the 
orange-red colored colonies, rosette shaped, devoid of hollow center and 2-3 mm in diameter. 
Variability in colony morphology, however, remained and the appropriate colonies had to be picked up 
for preparing the inoculum of each experiment. Addition of yeast extract to the fermentation medium at 
different times increased rifamycin B production. The highest antibiotic production was obtained upon 
the addition of 0.1% yeast extract after 2 days of incubation, where the yield increased from 1.15 to 1.95 
g/l (70%). The use of 1.8% KNO3 in the fermentation medium, instead of  0.96% (NH4)2SO4,  markedly 
increased  rifamycin B production from 1.15  to 2.92  g/l (154%). It was also observed, upon 
microscopical examination,  that KNO3 decreased branching and fragmentation of the mycelia in the 
fermentation medium. 
 





Among infectious diseases, tuberculosis remains a 
leading cause of death worldwide. It is estimated that 
over 8 million people contract tuberculosis each year, and 
approximately 2 to 3 million people die of this disease. In 
addition, it is thought that as many as 2 billion people 
have been exposed to the tuberculosis bacillus and are 
therefore at risk of developing active disease. This 
problem is further compounded by a dramatic increase in 
multidrug-resistant strains of Mycobacterium tuberculosis. 
An additional factor is human immunodeficiency virus, 
which has significantly increased the incidence of 
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Cock and Chaisson, 1999; Dye et al., 1999; Keshavjee 
and Bacerra, 2000; WHO, 2002 ). Rifampicin is 
considered one of the most effective antibiotics for the 
treatment of tuberculosis. Apart from its application 
against pathogens of tuberculosis and leprosy, it has also 
been found to be effective against several pathogens 
including Mycobacterium avium and penicillin-resistant 
pneumococci (Anne et al., 2000; Anon, 1999; Reynaldo-
Dietze et al., 2001; Russell, 1998). 
Rifamycins are produced mainly by the Gram-positive 
bacterium Amycolatopsis mediterranei, previously named 
Streptomyces mediterranei and later Nocardia 
mediterranei, which was first isolated from the soil at a 
French pine forest (Pape and Rehm, 1985). Rifamycins 
were first isolated from a fermentation culture at the 
Lepetit Laboratory in Milan, Italy, by Sensi and 






different types of rifamycins (A, B, C, D, E, S, SV etc.)  
according to the conditions of production. These 
rifamycins are usually interconvertable by chemical 
means and vary considerably in their antimicrobial 
spectrum and extent of activity. Being more stable, easier 
to purify, soluble at physiological pH and good starting 
material for the synthesis of active derivatives such as 
rifampicin, rifamycin B was chosen for development 
(Krishna et al., 2000; Pape and Rehm, 1985; Sensi and 
Thiemann, 1967). 
It has been previously reported that members of the 
genus streptomyces show genetic instability and, in 
several cases, variants with altered abilities to elaborate 
antibiotics (Fishman and Gershberger, 1983; Ono et al., 
1982; Schrempf, 1982). Inorganic and organic nitrogen 
compounds have been reported to play a key role in 
promoting rifamycin biosynthesis by serving either as a 
precursor or stimulant (Gresham and Inamine, 1986; Lee 
and Rho, 1994). 
This study aimed  at selection of the most active 
antibiotic producing colony from A. mediterranei–RCP 
1001 (N1) strain, which suffered generally from low and 
inconsistent productivity of around 500 mg/l of rifamycin 
B. In addition, the effect  of KNO3 and yeast extract on 
rifamycin B production was studied. 
 
 




A. mediterranei–RCP 1001 (N1) strain was obtained from El-Nasr 
Company for Pharmaceutical Chemicals, Egypt. The organism was 
maintained on Q/2 agar slants and propagated on Bennett’s agar. 
Selected colonies were subcultured onto Q/2 agar slants and stored 
at 4°C to be used within 27 days. For long term storage, the surface 






Chemicals used throughout this work were of laboratory reagent 
grade unless otherwise indicated. Glucose, KNO3, NaNO2 and 
propylene glycol were the products of ADWIC, Egypt. Sodium 
diethyl barbiturate (SDB) was the product of Grindstedvaerket A/S, 
Denmark. Potassium sodium tartarate tetrahydrate, 
3,5_dinitrosalicylic acid, CaCO3, MgSO4.7H2O, FeSO4.7H2O, 
KH2PO4, ZnSO4.7H2O, CoCl2.6H2O, (NH4)2SO4 and NaOH were the 
products of E. Merck, Darmstadt, Germany. Glacial acetic acid was 





Yeast extract, malt extract, beef extract, tryptone, skim milk and 
bacto agar were the products of Difco Laboratories, Detroit, U.S.A. 
Soybean meal, oat flakes and peanut meal were obtained from  
local commercial suppliers. 
Bennett’s agar medium was used for propagation and selection 
and consisted of: beef extract, 1.0 g; tryptone, 2.0; yeast extract 
1.0g; dextrose 12.0; bacto agar 20.0g and distilled water to 1000 
ml. The pH was adjusted to 7.2 (Margalith and Beretta, 1960).  Q/2 
agar medium was used  for  maintenance  and  consisted  of:  yeast  




extract, 4.0 g; malt extract, 10.0 g; dextrose, 4.0 g; oat flakes, 20.0 
g; bacto agar, 20.0 g and distilled water to 1000ml. The pH was 
adjusted to 6.9. Vegetative medium (V1) was used for preparation 
of inoculum and consisted of: dextrose, 20.0 g; soybean meal, 20.0 
g; MgSO4.7H2O, 0.4 g; CaCO3, 2.5 g; FeSO4.7H2O, 0.01 g; 
ZnSO4.7H2O, 0.05 g; CoCl2.6H2O, 0.003 g and distilled water to 
1000 ml. The pH was adjusted to 6.7. Fermentation medium (F1) 
was used for the antibiotic production and consisted of: peanut 
meal, 25.0 g; soybean meal, 10.0 g; dextrose, 140.0 g; propylene 
glycol, 10.0 ml; sodium diethyl barbiturate, 1.7g; (NH4)2SO4, 9.6g; 
CaCO3,11.0g; MgSO4.7H2O, 1.0g; FeSO4.7H2O, 0.005g; 
ZnSO4.7H2O ,0.012 g; KH2PO4, 1.0 g; CoCl2.6H2O, 0.003 g and   
distilled water to 1000ml. The pH was adjusted to 8.1. 
 
 
Strain propagation and selection 
 
One loopful from the culture on Q/2 agar slant was transfered into a 
sterile tube containing 6 ml of normal saline and seven glass beads, 
then  homogenized by vortex for 5 min and ten-fold serial dilutions 
were prepared in normal saline. Aliquots of 0.1 ml  from  dilutions 
10-5, 10-6, 10-7, and 10-8 were transfered onto the surface of 
Bennett’s agar plates. The plates were incubated at 28°C for one 
day then inverted, and the incubation was continued for 13 days.  
Plates with 15–30 well distinguished colonies were used for 
selection. Developed colonies with different morphological 
characteristics were selected and characterized. Colonies showing 
secondary surface development of mycelia, as observed under the 
stereomicroscope, were rejected.   
Each of the selected colonies was suspended in one ml saline 
and homogenized by vortex. Aliquots of 0.1 ml of this mycelial 
suspension were used to inoculate each of 3 slants of Q/2 medium 
and incubated at 28°C for 8 days. Slants showing homogenous 
growth, tough surface and dark red color were selected and stored 
at 4°C to be used within 27 days. 
  
 
Preparation of inoculum 
  
Surface growth of the selected slant was harvested in flasks 
containing 100 ml of vegetative medium (V1). The flasks were 
incubated at 28°C in a rotary incubator shaker (Controlled 
Environment Incubator Shaker, New Brunswick Scientific Co., NJ, 
USA) at 100 rpm for 56 to 72 h. Flasks showing the following 
parameters were selected for inoculation of the fermentation 
medium: pH, 7.6-7.9; percentage packed mycelial volume (Rho et 
al., 1991), 9 – 12%; color, intense orange to red; time for methylene 
blue decolorization, 50 – 70 s. 
 
 
Determination of percentage packed mycelial volume   
(PMV) 
 
The percentage packed mycelial volume was determined as 
described by Rho et al. (1991). Twenty ml of the previously 
prepared vegetative culture were centrifuged at 4,000 rpm for 5 
min. After decantation, the mycelia were washed with saline by 
centrifugation three times, then resuspended in saline to the original 
volume. The resuspended mycelia were allowed to settle down for 
20 min in 25 ml measuring cylinder, then the packed mycelial 
volume was measured and the percentage was determined. 
 
 
Decolorization  of methylene blue 
 
One ml of 1% methylene blue solution was added to 10 ml of the  
vegetative culture, mixed well and the decolorization time was 
determined. 
 




Table 1. The morphological characteristics of the different colonies of A. mediterranei on Bennett’s agar medium and their 
corresponding rifamycin B production. 
 
Colony      
type 
      Diameter 
        (mm) 
Morphological characteristics Range* of  Rifamycin B (g/l) 
1 2-3 Orange-red, rosette, irregular edge. 1.03-1.2 
2 3-5 Orange, mucoid, flattened, irregular edge. 0.95-1.0 
3 7-10 Orange-red, folding toward the center irregular edge.  0.76-0.82 
4 3-5 Orange, mucoid, hollow center, irregular edge. 0.50-0.60 
5 5-7 Reddish orange, mucoid, rounded, irregular edge. 0.70-0.80 
6 1-2 Reddish brown, mucoid, irregular edge. 0.62-0.70 
 




Production of rifamycin B in shake flasks 
         
The fermentation was carried out in six flasks each containing 50 ml 
of the fermentation medium (F1) and inoculated with 2.5 ml (5% v/v) 
of the inoculum. The flasks were incubated at 28°C in a rotary 
incubator shaker at 250 rpm for 8 days. Rifamycin B concentration, 
remaining glucose concentration and pH were determined in each 




Determination of remaining glucose concentration 
    
Remaining glucose concentration in the fermentation broth was 
determined by the dinitro salicylic acid method as described by 
Bernfeld (1955).  
 
 
Assay of rifamycin B 
 
The concentration of rifamycin B in the fermentation broth was 
determined spectrophotometrically as described by Pasqualucci et 





The morphological characteristics of the growing colonies 
on Bennett’s agar plates showed considerable 
morphological variation as indicated in Table 1 and      
illustrated in Figure 1. In addition, a considerable 
variation in rifamycin B production by the different types 
of colonies was observed (Table 1). The highest yield of 
rifamycin B was obtained by using colony type 1, which 
has orange-red color, rosette shape, devoid of a hollow 
center and 2-3 mm in diameter.  
Microscopical examination of the culture in the 
vegetative medium (V1) of the six colony types showed 
Gram–positive short thin filaments arranged radially 
around hollow centers and no spores could be detected 
(Figure 2). Microscopical examination of the culture in the 
fermentation medium (F1) varied with time where  the 
mycelia showed frequent branching at the early 
exponential phase (day 2–4), followed by increased 
branching and subsequent gradual fragmentation into 
short rods   (day 4-6). 
                            
Colony type 1                       Colony type 2 
 
 
                       
Colony type 3                       Colony type 4 
 
 
                              
Colony type 5                       Colony type 6 
  
Figure 1. Different colony types of A. mediterranei grown on 






Figure 2. A. mediterranei grown in early stage in fermentation 
medium (F1) as seen under the microscope stained with methylene 






The replacement of 4.5% of the glucose content in F1 
medium with 4.5% glycerol decreased rifamycin B 
production (Figure 3). Elimination of or increasing 
KH2PO4 concentration above 0.1% decreased the 
production of rifamycin B  (Figure 3). The addition of 
0.05, 0.1 and 0.2% of yeast extract at different times of 
the fermentation process increased rifamycin B 
production (Figures 3 and 4). The highest increase was 
obtained when 0.1% yeast extract was added after 2 
days  of  incubation, where  the  yield  increased  from  
1.15 g/l  to 1.95 g/l (70%). The addition of 0.9 and 1.8% 
KNO3, instead of 0.96% (NH4)2SO4, to the F1 medium 
increased rifamycin B production from 1.15 g/l to 2.74 g/l 
and to 2.92 g/l, respectively (Figure 5). Furthermore, the 
microscopical examination of the mycelia in the 
fermentation medium containing KNO3 revealed a 






























Figure 3. Effect of addition of yeast extract after 2 days, 
replacement of 4.5% glucose with 4.5% glycerol and the use of 
different concentrations of KH2PO4, in F1 medium, on rifamycin B 






Commercial production of an antibiotic requires the use 
of a fairly stable strain with consistent high productivity. 
Such consistancy could be a function of both the strain 
and of the process. In the present work we emphasized 
the selection and identification of distinguishing 
characteristics of the most productive variant for a strain 
with  potential  commercial  application  for  production  of  




Figure 4. Effect of addition of 0.05 and 0.2% yeast  extract to F1 
























   
   
   

























(P) F1 (P) 0.9% KNO3 (P) 1.8% KNO3
(S) F1 (S) 0.9% KNO3 (S) 1.8% KNO3
pH F1 pH  0.9% KNO3 pH 1.8% KNO3  
 
Figure 5. Effect of replacement of (NH4)2SO4 with KNO3 in F1 
medium on rifamycin B production (P), remaining glucose 




rifamycin B and aimed at defining some fundamental 
conditions necessary to maintain such variant at high 
levels of antibiotic productivity.   
The morphological characteristics of the growing 
colonies on Bennett’s agar medium showed considerable 
variation, where 6 different colony types were recognized. 



















Control 0% KH2PO4 0.2% KH2PO4
0.3% KH2PO4 4.5% glycerol 0.05% yeast extract























Control     1      2     3 1      2      3
 




showed variation in the color and the homogeneity of the 
surface growth. The highest yield of rifamycin B was 
obtained by using type 1 colonies (Figure 1). Such intra-
strain morphological variability and correlation between 
colony morphology and antibiotic productivity is not 
uncommon within species of the genus Streptomyces 
(Fishman and Gershberger, 1983; Ono et al., 1982; 
Schrempf, 1982). In a study using a different strain of A. 
mediterranei (CBS 42575), Farid et al. (1996) 
demonstrated that the highest yield of rifamycin B (0.78 
g/l) was obtained by using the red colored colonies, 2–3 
mm in diameter and rosette shape, a somewhat similar 
description of our colony type 1. Unfortunately, we could 
not examine a colored picture of those author’s colonies, 
which we can use for comparison. It can be concluded 
that using our strain of A. mediterranei, the least 
productive colonies are buff, orange or brown in color, <2 
mm or >3 mm in size, hollow-centered or folding toward 
the center, mucoid, regular edge while the most 
productive colonies are orange-red in color, rosette 
shape with irregular edge and 2-3 mm in size.     
Microscopical examination of the organism showed 
Gram-positive short thin filaments and no spores could 
be detected. It has previously been reported that 
sporulation is best noticeable in chemically defined media 
(Margalith and Beretta, 1960). In the fermentation 
medium (F1), the mycelia showed frequent branching 
followed by subsequent gradual fragmentation into short 
rods. Branching and fragmentation of the mycelia was 
also reported by Lee and Rho (1994). Several authors 
reported the tendency of the mycelia to fragment into 
short rods. It should be noted that such fragmentation as 
well as the presence of meso-diaminopimelic acid and of 
arabinose and the absence of glycine are characteristics 
of the genus Nocardia (Pape and Rehm, 1985;Thiemann 
et al., 1969). However, Nocardia mediterranei was moved 
from the genus Nocardia to a new genus Amycolatopsis, 
on the basis of lacking mycolic acids in the cell wall and 
being not susceptible to typical nocardia phages (Lancini 
and Cavalleri, 1997; Le Chevalier et al., 1986).  
The maximum rifamycin B production by the selected 
typical colony type 1 ranged between 1.03 g/l and 1.2 g/l. 
Although this yield is considerably higher than that 
reported by Farid el al. (1996), it is still too low for 
industrial appllication. This low yield and even this limited 
fluctuation in production are considered major problems 
in industry. Attempts to optimize the fermentation process 
were carried out by studying the effect of inorganic 
phosphate and of organic and inorganic nitrogen sources.
 Phosphate has been known to act as a regulatory 
substance in the synthesis of primary and secondary 
metabolites in microorganisms (Mertz and Doolin, 1973). 
In our study, increasing the concentration of  KH2PO4  
above 0.1% caused a marked decrease in rifamycin B 
production (36- 45%), while total elimination of KH2PO4 
caused only 12% decrease (Figure 3). This rather 





production of one rifamycin is influenced by synthesis of 
another (Lal et al.,1995). For example, Lancini and Sensi 
(1967) reported that in production of rifamycin B, any shift 
in metabolism which stimulates simultaneous production 
of other rifamycins may suppress synthesis of rifamycin 
B. More specifically, using a strain of Nocardia 
mediterranei which produced rifamycin B and to a lesser 
extent rifamycin Y, they noted that although several 
fermentation variables did not suppress production of 
rifamycin Y, decreasing the level of KH2PO4 drastically 
did - and hence increased production of rifamycin B. Our 
results may reflect a similar case, whereby an increase in 
KH2PO4 favors synthesis of a rifamycin which suppresses 
synthesis of rifamycin B rather than result in a total lower 
yield of rifamycins.  
Yeast extract was reported by Kawaguchi et al. (1984) 
to play a regulatory role in the production of rifamycin B 
by Nocardia. They further reported that yeast extract 
contains 3’-(1-butyl phosphoryl) adenosine (the B-factor) 
that regulates the production of the rifamycin precursor 3-
amino-5-hydroxybenzoic acid which is the starter unit 
(chain initiator) for the assembly of a polyketide in 
rifamycin biosynthesis. In our study, the addition of 0.05, 
0.1 and 0.2% yeast extract at different times of the 
fermentation process (1, 2 and 3 days) increased 
rifamycin B production (Figures 3 and 4). The highest 
yield was obtained upon using 0.1%  yeast extract after 2 
days of incubation with 70% higher yield than the control 
(8 days, total fermentation time). It was observed that, at 
all tested concentrations, the highest stimulation of 
rifamycin B production was when yeast extract was 
added after 2 days of incubation. It is further noted that 
the lowest concentration of yeast extract (0.05%) showed 
only moderate influence on antibiotic production, while 
the highest concentration (0.2%) showed its influence 
from the 4th day onward. Interestingly, a concentration of 
0.1% yeast extract, while showing only a moderate 
influence up to the 6th day, gave a sharp increase in 
antibiotic productivity afterwards.  Kawaguchi et al. 
(1988) reported that the addition of B-factor, isolated from 
yeast extract, after 2 days of incubation caused maximum 
rifamycin B production and that earlier addition at day 0 
and day 1 gave slightly lower production. They suggested 
that this was probably due to degradation of the B-factor 
before initiation of the antibiotic biosynthesis. 
In our study, the fermentation medium F1 contained 
0.96% (NH4)2SO4 as inorganic nitrogen source, which 
has also been used by Lysko and Gorskaia (1986). They 
studied the influence of various forms of inorganic 
nitrogen on biosynthesis of rifamycin B and found that 
only (NH4)2SO4 provided the pH levels of the fermentation 
broth suitable for the antibiotic biosynthesis and the 
highest levels of antibiotic production. However, Lee and 
Rho (1994) reported that inoganic nitrogen sources play 
an important role in determining the production profile of 
rifamycin B with KNO3 showing  a positive influence on 






1.8% KNO3 (representing half and same nitrogen 
equivalent to 0.96% (NH4)2SO4, respectively) was tested. 
When 0.9% KNO3 was used, production by the 8th day 
was 138% higher while with 1.8% KNO3 antibiotic 
production was more sluggish but showed a very steep 
positive slope starting on the 6th day with 154% increase 
by the 8th day. From our results, it was concluded that 
KNO3 was superior to (NH4)2SO4 as an inorganic nitrogen 
source for the production of rifamycin B. Since the 
optimum pH during the trophophase was reported to be 
6.5 (Lee et al., 1983), and since the pH profiles for the 
production with 0.9 and 1.8% KNO3 did not seem to be 
significantly different (Figure 5), a pH effect may not 
explain the different antibiotic productivities under the 2 
conditions. 
An interesting observation was that while a slightly 
higher rifamycin B production occured with 1.8% than 
with 0.9% KNO3 by day 8, productivity trends were much 
higher with 0.9% than 1.8% KNO3 at all other time 
samples. In both cases however, production almost 
always significantly exceeded the control but the fact 
remained that with 1.8% KNO3 the slower start was 
compensated for by a consistant positive trend in 
apparent rate of production, when compared to 0.9% 
KNO3. Unfortunately, we were not able to determine 
biomass and hence specific production rates. A possible 
significant observation is that in all cases glucose 
consumption was rather slow  and incomplete but 
occured at somewhat higher apparent rates with 
(NH4)2SO4, 0.9% KNO3 and 1.8% KNO3, respectively in 
decreasing order (Figure 5) especially during the 
trophophase. The faster utilization of glucose with 
(NH4)2SO4 than with KNO3  was also observed by Lee 
and Rho (1994) and might be the cause of the lower yield 
of the antibiotic with (NH4)2SO4 in our study as explained 
by Pape and Rehm (1985).  
The microscopical characteristics of the mycelia grown 
with (NH4)2SO4 differed from that with KNO3. In addition, 
the culture medium was much more viscous and the 
mycelia were more profoundly branched in the medium 
containing (NH4)2SO4 than that containing KNO3. It is 
possible that this excessive branching caused an 
increase in viscosity of the culture medium and 
subsequently interfered with mixing and aeration. It may 
be concluded that the microscopical characteristics of  A. 
mediterranei were significantly affected by the 
constituents of the culture media which possibly also 
influenced availability of oxygen, and that rifamycin B 
productivity was also related to morphological changes 
as previously reported by Rho et al. (1991) and Lee and 
Rho (1994). 
In conclusion, selection of the most productive colony 
type increased the yield of rifamycin B from 0.5 g/l to a 
range of 1.03 to1.2 g/l and the use of 0.1% yeast extract 
or 1.8% KNO3 led to a further increase in the yield to 1.95 
g/l (70%) and 2.92 g/l (154%), respectively. This yield is 
still   much   lower   than   the   level   for   the    economic  




production of rifamycin B. Thus, several studies to 
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